Sida Cordifolia
OTHER NAME(S): Abutilon en Épi, Bala, Bariar, Chitramutti, Country Mallow, Guimauve, Heartleaf, Herbe de Douze Heures, Indian Chikana, Indian Ephedra, Khareti, Malva Blanca, Malva-Branca, Malva-Branca-Sedosa, Mauve Blanc, Mauve du Pays, Silky White Mallow, Vatya, White Mallow, Sida cordifolia, Heartleaved Sida, Heart-Leaf Sida
Overview
Sida cordifolia is a shrub native to India that now grows worldwide. It's a common ingredient in herbal preparations in many systems of traditional medicine.
Sida cordifolia contains ephedrine, which is an amphetamine-like stimulant.
Despite serious safety concerns, people use Sida cordifolia for asthma, allergies, fatigue, erectile dysfunction, common cold, and many other conditions, but there is no good scientific evidence to support these uses.
Sida cordifolia contains ephedrine, which is an amphetamine-like stimulant that can cause harmful side effects. Since April 2004, the US FDA has banned the sale of ephedra, Sida cordifolia, and other products that contain ephedrine. Don't confuse Side cordifolia with Chinese Mallow, Mallow, or Marshmallow. These are not the same.
Uses
We currently have no information for Sida Cordifolia overview.
Side Effects
When taken by mouth: Sida cordifolia is likely unsafe. It contains ephedrine and is banned in the US due to safety concerns. Ephedrine has been linked to serious side effects including high blood pressure, heart attacks, loss of consciousness, and death.
Precautions
When taken by mouth: Sida cordifolia is likely unsafe. It contains ephedrine and is banned in the US due to safety concerns. Ephedrine has been linked to serious side effects including high blood pressure, heart attacks, loss of consciousness, and death.
Pregnancy and breast-feeding: Sida cordifolia is likely unsafe. Avoid use.
Anxiety: Sida cordifolia contains ephedrine. Large doses of ephedrine might cause or make anxiety worse. Do not use Sida cordifolia if you have anxiety.
Heart conditions: Sida cordifolia contains ephedrine, which can stimulate the heart. This might make chest pain and irregular heartbeat worse. Do not use Sida cordifolia if you have a heart condition.
Diabetes: Sida cordifolia might interfere with blood sugar control in people with diabetes. Do not use Sida cordifolia if you have diabetes.
A movement disorder called essential tremor: Sida cordifolia might make essential tremor worse due to its stimulant effects. Do not use Sida cordifolia if you have essential tremor.
High blood pressure: Sida cordifolia contains ephedrine, which can increase blood pressure. This might make high blood pressure worse. Do not use Sida cordifolia if you have high blood pressure.
Thyroid problems: Sida cordifolia might stimulate the thyroid and make thyroid problems worse. Do not use Sida cordifolia if you have a thyroid disorder.
Kidney stones: Sida cordifolia contains ephedrine. Ephedrine can cause kidney stones. Do not use Sida cordifolia if you have kidney stones.
Narrow-angle glaucoma: Sida cordifolia might make glaucoma worse by causing the pupils to dilate. Do not use Sida cordifolia if you have narrow-angle glaucoma.
A tumor on the adrenal gland (pheochromocytoma): Sida cordifolia might make the symptoms of pheochromocytoma worse. Do not use Sida cordifolia if you have pheochromocytoma.
Interactions
Moderate Interaction
Be cautious with this combination
- Medications for diabetes (Antidiabetes drugs) interacts with Sida CordifoliaSida cordifolia might increase blood sugar levels. Taking Sida cordifolia along with diabetes medications might reduce the effects of these medications. Monitor your blood sugar closely.
- Medications that can cause an irregular heartbeat (QT interval-prolonging drugs) interacts with Sida CordifoliaSida cordifolia might affect electrical currents in the heart. This can increase the risk of having an irregular heartbeat. Some medications can have this same effect. Taking Sida cordifolia with these medications might increase the risk for a serious heart issue.
- Methylxanthines interacts with Sida CordifoliaSida cordifolia can simulate the body. Methylxanthines also stimulate the body. Taking Sida cordifolia with methylxanthines might cause side effects such as jitteriness, nervousness, a fast heartbeat, high blood pressure, and anxiety.
- Stimulant drugs interacts with Sida CordifoliaStimulants, such as amphetamines and cocaine, speed up the nervous system. By speeding up the nervous system, stimulant medications can increase blood pressure and speed up the heartbeat. Sida cordifolia can also speed up the nervous system. Taking Sida cordifolia along with stimulant drugs might cause serious problems including increased heart rate and high blood pressure.
- Dexamethasone (Decadron) interacts with Sida CordifoliaSida cordifolia might increase how quickly the body breaks down dexamethasone. This might decrease the effects of dexamethasone.
- Ergot derivatives interacts with Sida CordifoliaSida cordifolia can increase blood pressure. Ergot derivatives can also increase blood pressure. Taking Sida cordifolia with ergot derivatives might increase blood pressure too much.
- Medications for depression (MAOIs) interacts with Sida CordifoliaSida cordifolia contains chemicals that can increase blood pressure. Some medications used for depression can also increase blood pressure. Taking Sida cordifolia with these medications might increase blood pressure too much. Some common MAOIs include phenelzine (Nardil), selegiline (Zelapar), and tranylcypromine (Parnate).
Dosing
Despite being banned in the US, Sida cordifolia is still found in some dietary supplements. The active chemical in Sida cordifolia, ephedrine, can cause serious, life-threatening side effects.
References
- Horton TJ, Geissler CA. Aspirin potentiates the effect of ephedrine on the thermogenic response to a meal in obese but not lean women. Int J Obes 1991;15:359-66.
- Dulloo AG, Miller DS. Aspirin as a promoter of ephedrine-induced thermogenesis: potential use in the treatment of obesity. Am J Clin Nutr 1987;45:564-9.
- Okada S, Rohan PJ, Miller FW, et al. Myopathies following ingestion of special nutritional products. Arthritis Rheum 1996;39:349.
- Zaacks SM, Klein L, Tan CD, et al. Hypersensitivity myocarditis associated with ephedra use. J Toxicol Clin Toxicol 1999;37:485-9.
- Powell T, Hsu FF, Turk J, Hruska K. Ma-huang strikes again: ephedrine nephrolithiasis. Am J Kidney Dis 1998;32:153-9.
- Theoharides TC. Sudden death of a healthy college student related to ephedrine toxicity from a ma-huang containing drink. J Clin Psychopharmacol 1997;17:437-9.
- Vahedi K, Domingo V, Amarenco P, Bousser MG. Ischemic stroke in a sportsman who consumed MaHuang extract and creatine monohydrate for bodybuilding. J Neurol Neurosurg Psychiatr 2000;68:112-3.
- Doyle H, Kargin M. Herbal stimulant containing ephedrine has also caused psychosis. BMJ 1996;313:756.
- For Dieter, Nearly the Ultimate Loss. The Washington Post. Available at: https://www.washingtonpost.com/archive/politics/2000/03/19/for-dieter-nearly-the-ultimate-loss/c0f07474-489d-4f44-bc17-1f1367c956ae/ (Accessed 19 March 2000).
- FDA Takes Aim at Ephedra. The Washington Post. Available at: https://www.washingtonpost.com/archive/politics/2000/03/19/fda-takes-aim-at-ephedra/4ce534a7-d291-44ec-88a8-38e97ff27e3b/ (Accessed 19 March 2000).
- Louis E. Tremor disorders: identification and treatment. Medical Update for Psychiatrists 1997;2:172-6.
- FDA. Proposed rule: dietary supplements containing ephedrine alkaloids. Available at: http://www.verity.fda.gov (Accessed 25 January 2000).
- Boozer CN, Nasser JA, Heymsfield SB, et al. An herbal supplement containing Ma Huang-Guarana for weight loss: a randomized, double-blind trial. Int J Obes Relat Metab Disord 2001;25:316-24.
- Kanth VR, Diwan PV. Analgesic, anti-inflammatory and hypoglycaemic activities of Sida cordifolia. Phytother Res 1999;13:75-7.
- Homer KA, Manji F, Beighton D. Inhibition of peptidase and glycosidase activities of Porphyromonas gingivalis, Bacteroides intermedius and Treponema denticola by plant extracts. J Clin Periodontol 1992;19:305-10.
- Anon. Sida Cordifolia. Metro Marketing, Inc. Available at: https://metromkt.net/viable/1sidacor.shtml (Accessed 9 March 2000).
- Anon. Sida Cordifolia Linn. Available at: https://www.modern-natural.com/sida_cordifolia.htm (Accessed 9 March 2000).
- Gurley BJ, Gardner SF, Hubbard MA. Content versus label claims in ephedra-containing dietary supplements. Am J Health Syst Pharm 2000;57:963-9.
- White LM, Gardner SF, Gurley BJ, et al. Pharmacokinetics and Cardiovascular Effects of Ma-Huang (Ephedra sinica) in Normotensive Adults. J Clin Pharmacol 1997;37:116-22.
- Haller CA, Benowitz NL. Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids. N Engl J Med 2000;343:1833-8.
- Leikin JB, Klein L. Ephedra causes myocarditis. Clin Toxicol 2000;38:353-4.
- Jacobs KM, Hirsch KA. Psychiatric complications of Ma-huang. Psychosomatics 2000;41:58-62.
- Dulloo AG. Herbal simulation of ephedrine and caffeine in treatment of obesity. Int J Obes Relat Metab Disord 2002;26:590-2.
- Samenuk D, Link MS, Homoud MK, et al. Adverse cardiovascular events temporally associated with ma huang, an herbal source of ephedrine. Mayo Clin Proc 2002;77:12-6.
- Haller CA, Jacob P 3rd, Benowitz NL. Pharmacology of ephedra alkaloids and caffeine after single-dose dietary supplement use. Clin Pharmacol Ther 2002;71:421-32.
- Greenway FL, Raum WJ, DeLany JP. The effect of an herbal dietary supplement containing ephedrine and caffeine on oxygen consumption in humans. J Altern Complement Med 2000;6:553-5.
- Bell DG, Jacobs I, Ellerington K. Effect of caffeine and ephedrine ingestion on anaerobic exercise performance. Med Sci Sports Exerc 2001;33:1399-403.
- Boozer CN, Daly PA, Homel P, et al. Herbal ephedra/caffeine for weight loss: a 6-month randomized safety and efficacy trial. Int J Obes Relat Metab Disord 2002;26:593-604.
- Morgenstern LB, Viscoli CM, Kernan WN, et al. Use of Ephedra-containing products and risk for hemorrhagic stroke. Neurology 2003;60:132-5. .
- Dulloo AG, Miller DS. Ephedrine, caffeine and aspirin: "over-the-counter" drugs that interact to stimulate thermogenesis in the obese. Nutrition 1989;5:7-9.
- Kalman D, Incledon T, Gaunaurd I, et al. An acute clinical trial evaluating the cardiovascular effects of an herbal ephedra-caffeine weight loss product in healthy overweight adults. Int J Obes 2002;26:1363-66..
- Schweinfurth J, Pribitkin E. Sudden hearing loss associated with ephedra use. Am J Health Syst Pharm 2003;60:375-7.
- Food and Drug Administration, HHS. Final rule declaring dietary supplements containing ephedrine alkaloids adulterated because they present an unreasonable risk; Final rule. Fed Regist 2004;69:6787-6854.
- Kockler DR, McCarthy MW, Lawson CL. Seizure activity and unresponsiveness after hydroxycut ingestion. Pharmacotherapy 2001;21:647-51..
- Yates KM, O'Connor A, Horsley CA. "Herbal Ecstasy": a case series of adverse reactions. N Z Med J 2000;113:315-7..
- Levisky JA, Karch SB, Bowerman DL, et al. False-positive RIA for methamphetamine following ingestion of an Ephedra-derived herbal product. J Anal Toxicol 2003;27:123-4.
- Walton R, Manos GH. Psychosis related to ephedra-containing herbal supplement use. South Med J 2003;96:718-20..
- Jenkins DJ, Wesson V, Wolever TM, et al. Wholemeal versus wholegrain breads: proportion of whole or cracked grain and the glycaemic response. BMJ 1988;297:958-60.
- Baker J, Zhang X, Boucher T, Keyler D. Investigation of quality in ephedrine-containing dietary supplements. Journal of Herbal Pharmacotherapy 2003;3:5-17.
- McBride BF, Karapanos AK, Krudysz A, et al. Electrocardiographic and hemodynamic effects of a multicomponent dietary supplement containing ephedra and caffeine: a randomized controlled trial. JAMA 2004;291:216-21.
- Brooks SM, Sholiton LJ, Werk EE Jr, Altenau P. The effects of ephedrine and theophylline on dexamethasone metabolism in bronchial asthma. J Clin Pharmacol 1977;17:308-18.
- Gardner SF, Franks AM, Gurley BJ, et al. Effect of a multicomponent, ephedra-containing dietary supplement (Metabolife 356) on Holter monitoring and hemostatic parameters in healthy volunteers. Am J Cardiol 2003;91:1510-3, A9.
- Soni MG, Carabin IG, Griffiths JC, Burdock GA. Safety of ephedra: lessons learned. Toxicol Lett 2004;150:97-110.
- Haller CA, Jacob P 3rd, Benowitz NL. Enhanced stimulant and metabolic effects of combined ephedrine and caffeine. Clin Pharmacol Ther 2004;75:259-73.
- Wilson BE, Hobbs WN. Case report: pseudoephedrine-associated thyroid storm: thyroid hormone-catecholamine interactions. Am J Med Sci 1993;306:317-9.
- Ujino H, Morimoto O, Yukioka H, Fujimori M. [Acute angle-closure glaucoma after total hip replacement surgery]. Masui 1997;46:823-6.
- Gunatilaka AA, Sotheeswaran S, Balasubramaniam S, et al. Studies on medicinal plants of Sri Lanka. III. Pharmacologically important alkaloids of some sida species. Planta Med 1980;39:66-72.
- Franzotti EM, Santos CV, Rodrigues HM, et al. Anti-inflammatory, analgesic activity and acute toxicity of Sida cordifolia L. (Malva-branca). J Ethnopharmacol 2000;72:273-7.
- Franco, C. I., Morais, L. C., Quintans-Junior, L. J., Almeida, R. N., and Antoniolli, A. R. CNS pharmacological effects of the hydroalcoholic extract of Sida cordifolia L. leaves. J Ethnopharmacol. 4-26-2005;98(3):275-279.
- Medeiros, I. A., Santos, M. R., Nascimento, N. M., and Duarte, J. C. Cardiovascular effects of Sida cordifolia leaves extract in rats. Fitoterapia 2006;77(1):19-27.
- Santos, M. R., Nascimento, N. M., Antoniolli, A. R., and Medeiros, I. A. Endothelium-derived factors and k+ channels are involved in the vasorelaxation induced by Sida cordifolia L. in the rat superior mesenteric artery. Pharmazie 2006;61(5):466-469.
- Silva, R. L., Melo, G. B., Melo, V. A., Antoniolli, A. R., Michellone, P. R., Zucoloto, S., Picinato, M. A., Franco, C. F., Mota, Gde A., and Silva, Ode C. Effect of the aqueous extract of Sida cordifolia on liver regeneration after partial hepatectomy. Acta Cir.Bras. 2006;21 Suppl 1:37-39.
- Sutradhar, R. K., Rahman, A. M., Ahmad, M., Bachar, S. C., Saha, A., and Roy, T. G. Anti-inflammatory and analgesic alkaloid from Sida cordifolia linn. Pak.J Pharm Sci 2007;20(3):185-188.
- Philip, B. K., Muralidharan, A., Natarajan, B., Varadamurthy, S., and Venkataraman, S. Preliminary evaluation of anti-pyretic and anti-ulcerogenic activities of Sida cordifolia methanolic extract. Fitoterapia 2008;79(3):229-231.
- Ashok, P., Arulmozhi, S., Bhaskara, B. P., and Rajendran, R. D. Comparative Food Intake Inhibitory Activity of Sida cordifolia Bala L. and Withania somniferia L. in rats. Journal of Natural Remedies 2007;7(2):289-293.
- Dhalwal, K., Deshpande, Y. S., Purohit, A. P., and Kadam, S. S. Evaluation of the Antioxidant Activity of Sida cordifolia Bala. Pharmaceutical Biology 2005;43(9):754-761.
- Chen, W. L., Tsai, T. H., Yang, C. C., and Kuo, T. B. Acute effects of ephedra on autonomic nervous modulation in healthy young adults. Clin.Pharmacol.Ther. 2010;88(1):39-44.
- Phosphatidylcholine. Altern Med Rev 2002;7(2):150-4.
- Momin MA, Bellah SF, Rahman SM, et al. Phytopharmacological evaluation of ethanol extract of Sida cordifolia L. roots. Asian Pac J Trop Biomed 2014;4(1):18-24.
- Sumanth M, Mustafa SS. Antistress, adoptogenic activity of Sida cordifolia roots in mice. Indian J Pharm Sci 2009;71(3):323-4.
- Konate K, Bassole IH, Hilou A, et al. Toxicity assessment and analgesic activity investigation of aqueous acetone extracts of Sida acuta Burn f. and Sida cordifolia L. (Malvaceae), medicinal plans of Burkina Faso. BMC Complement Altern Med 2012;12:120.
- Dinda B, Das N, Dinda S, et al. The genus Sida L. - A traditional medicine: its ethnopharmacological, phytochemical and pharmacological data for commercial exploitation in herbal drugs industry. J Ethnopharmacol 2015;176:135-76.